title: [Uneven efficacy of Viperfav® antivenom for the treatment of neurotoxic viper envenomations].
authors.forename: Michel
authors.initials: M
authors.lastname: Guiavarch
authors.forename: Marie
authors.initials: M
authors.lastname: Médus
authors.forename: Lucia
authors.initials: L
authors.lastname: Tichadou
authors.forename: Mathieu
authors.initials: M
authors.lastname: Glaizal
authors.forename: Luc
authors.initials: L
authors.lastname: de Haro
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy / Q000209:etiology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000997:Antivenins / Q000627:therapeutic use*; D003389:Cranial Nerve Diseases / Q000209:etiology; D004630:Emergencies; D005260:Female; D006230:Hand Injuries / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D009498:Neurotoxins / Q000506:poisoning*; D012206:Rhabdomyolysis / Q000209:etiology; D012909:Snake Bites / Q000150:complications / Q000628:therapy*; D013997:Time Factors; D014757:Viper Venoms / Q000737:chemistry / Q000506:poisoning*; D017819:Viperidae; D014946:Wound Infection / Q000188:drug therapy / Q000209:etiology; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000997:Antivenins; D009498:Neurotoxins; D014757:Viper Venoms